NCT00583323View on ClinicalTrials.gov

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Lymphoma

Interventions

DRUG

Lomotil

Orally 10ml of Lomotil

OTHER

Normal saline

10 ml orally

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER